No health agency approves marijuana or CBD to treat fibromyalgia. The FDA has approved no cannabis product for this condition. Evidence comes from small trials and patient surveys. Results are mixed. Some people report less pain and better sleep. Others report no change or side effects.
THC for Fibromyalgia: What to Buy and How to Dose Safely
What fibromyalgia is
Fibromyalgia causes widespread pain, fatigue, sleep problems, and trouble with memory. The CDC cites 2016 survey data: about 2% of US adults have the condition. That equals about 4 million people. Women receive the diagnosis more than men. Doctors use the 2010 and 2016 American College of Rheumatology criteria, which score pain sites and symptom severity. There is no blood test and no cure.
What the research shows
- A 2010 randomized trial tested nabilone, a synthetic THC analog, in 40 patients. Patients on nabilone reported better sleep and lower pain ratings than the placebo group. Side effects included dizziness and drowsiness.
- A 2011 observational study in PLOS ONE followed 28 patients who used cannabis on their own. They reported less pain and stiffness two hours after use. The study had no placebo group and no blinding.
- A 2018 Cochrane review found low-quality evidence that cannabis-based medicines can reduce chronic neuropathic pain by 50% or more in some patients. The reviewers did not find enough data to judge fibromyalgia on its own.
- Survey data from rheumatology clinics put cannabis use among fibromyalgia patients between about 10% and 33%. These numbers describe who uses the drug, not whether it works.
THC, CBD, and the difference
THC binds CB1 receptors in the brain and produces a high. CBD does not produce a high. Lab studies suggest CBD may interact with CB1, CB2, and serotonin receptors, but human trial data for fibromyalgia is scarce. Most CBD sold online is hemp-derived and contains less than 0.3% THC. Product labels often list a dose that does not match lab results. Third-party lab tests are the way to verify cannabinoid content.
US law
Cannabis is a Schedule I controlled substance under federal law. State rules differ. Some states list fibromyalgia or chronic pain as a qualifying condition for a medical cannabis card. Others do not. Hemp-derived CBD with less than 0.3% THC is legal under the 2018 Farm Bill, but some states restrict it.
Risks and limits
- Common side effects: dizziness, dry mouth, drowsiness, and short-term memory problems.
- THC can raise heart rate and trigger anxiety in some users.
- Cannabis interacts with opioids, benzodiazepines, and blood thinners.
- NIDA estimates about 1 in 10 adults who use cannabis develop cannabis use disorder.
- Inhaled smoke irritates the airways and links to chronic bronchitis.
Questions for a clinician
Ask about drug interactions with your current prescriptions. Ask how a product would be monitored. Bring lab reports if you use CBD. Track pain scores, sleep hours, and side effects in a log. No cannabis product is standardized, so dose control takes work.